View: All | News | Blog | Events

Version 3.4 of the Vivli platform has been released and is available to users. The key change with the new version of the platform is ...  > MORE
Vivli’s CEO, Rebecca Li, will speak on Day 3 at the Global Clinical Trials: Technology & Innovation webcase series. This online event will take place ...  > MORE
Vivli is delighted to announce the launch of our new Case Studies series, designed to highlight the work of researchers around the world who are ...  > MORE
Analyzing individual patient-level data (IPD) from completed clinical trials to glean additional insights about patient populations is a key benefit of data sharing and reuse. ...  > MORE
Vivli held a webinar to discuss recent developments in data privacy laws and their impact on data sharing. This webinar was held at 5pm CEST ...  > MORE
In a recent study led by Dr. Sarah Nevitt, a senior research associate at the University of Liverpool, a team of researchers examined the effectiveness ...  > MORE
Dr. João Sérgio Neves is an endocrinologist, based in the Faculty of Medicine of the University of Porto and São João Hospital in Porto, Portugal. ...  > MORE
PROCEEDINGS RECORDINGS Please find linked above the proceedings and a recording of the meeting. This includes separate recordings of all panels and the keynote sessions ...  > MORE
Please join Vivli at the National Academy of Medicine in Washington, DC on November 16, 2023 in Washington, D.C. for a strategic meeting to collectively ...  > MORE
Vivli is delighted to announce the addition of two keynote speakers to the agenda for our upcoming event, “Shaping the next 10 years in Data ...  > MORE
Awardees Announced for the Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome Vivli is pleased to announce the awardees of the Vivli ...  > MORE
Did you know there’s more on Vivli than just clinical trial data? The majority of our repository of data comes from clinical trial data, but ...  > MORE
Dr. Neeraj Narula is an Associate Professor of Medicine and Staff Gastroenterologist at McMaster University in Hamilton, Ontario, Canada. His primary research focus is on ...  > MORE
Vivli has launched the Vivli AMR Surveillance Open Data Re-use Challenge, funded by Wellcome. The data challenge aims to stimulate and support the innovative re-use ...  > MORE
Elena Myasoedova, M.D., Ph.D., is a clinical rheumatologist with specialty interest in inflammatory arthritis. She is an associate professor of medicine and epidemiology and clinical ...  > MORE
The Leona M. and Harry B. Helmsley Charitable Trust’s Type 1 Diabetes Program has launched an initiative to support innovative and practicable solutions to help ...  > MORE
Rebecca Li will be speaking at the NIA-DUKE-Alzheimer’s Association Workshop held on March 15-16th sponsored by the National Institute on Aging. The focus of the ...  > MORE
Learn how the Vivli repository is making it easier for scientists to share and access data, and how you can comply with the NIH’s data ...  > MORE
Vivli hosted a webinar to discuss applications of the SAFE Data Standard as defined in “Sharing Anonymized and Functionally Effective (SAFE) Data Standard for Safely ...  > MORE
“Enabling the Data Sharing Ecosystem” Vivli’s 2022 Annual Meeting was held on Wednesday, November 2nd, 2022, 9:00am – 12:00pm EST / 2:00  – 5:00pm CET ...  > MORE
The Leona M. and Harry B. Helmsley Charitable Trust’s Type 1 Diabetes Program announced the launch of their initiative to support novel, real-world solutions to ...  > MORE
The Vivli team, led by Executive Director Rebecca Li, recently authored a paper entitled “Health Data Sharing Platforms: Serving Researchers through Provision of Access to ...  > MORE
Vivli hosted CRDSA to explore findings of their newly published whitepaper, “A Review of BioPharma Sponsor Data Sharing Policies and Protection Methodologies.” The webinar was ...  > MORE
“We are thrilled to welcome Bayer as a member of Vivli,” said Rebecca Li, Vivli Executive Director. “We look forward to supporting researchers to request ...  > MORE
Vivli enthusiastically congratulates Dr. Monica Bertagnolli on her recent appointment as Director of the National Cancer Institute (NCI). Dr. Bertagnolli has served as a long-time ...  > MORE
“We are pleased that Ipsen has joined Vivli as a member,” said Rebecca Li, Vivli Executive Director. “By joining Vivli as a member, Ipsen is ...  > MORE
Clinical Trials- Informa Connect is hosting a hybrid event, “Future-Proof Your Clinical Data Disclosure, Transparency and Plain Language Summaries,” in June 2022. They will be ...  > MORE
“Creating Value by Working Together” Vivli’s 2021 Annual Meeting was held on November 3rd. This meeting served as a chance to allow researchers, data contributors, ...  > MORE
A new partnership between the Alzheimer’s Disease Data Initiative (ADDI) and Vivli expands access to critical clinical trial data from leading pharmaceutical companies. Today, the ...  > MORE
Vivli extends a warm welcome to our newest partner platform as a member, the Infectious Diseases Data Observatory (IDDO). “We are pleased IDDO is making their ...  > MORE
“We are delighted to welcome Shionogi as our newest member,” said Rebecca Li, Vivli Executive Director. “We are excited to facilitate Shionogi’s continued commitment to ...  > MORE
Version 2.0 of the Vivli platform has been released and is available to users. “The improvements to the underlying infrastructure of Vivli should have major ...  > MORE
Vivli board member and Duke University Professor, Eric Perakslis, met with Dr. Ashley Hopkins of Flinders University to discuss the importance of his team’s research ...  > MORE
Vivli co-founder and UCSF professor Dr. Ida Sim had the opportunity to interview Dr. Neeraj Narula from McMaster University to discuss the value of clinical ...  > MORE
Vivli extends a warm welcome to our newest partner platform as a member, the NIAID Clinical Trials Data Repository, AccessClinicalData@NIAID. “We are delighted to include AccessClinicalData@NIAID ...  > MORE
Vivli Board Member Dr. Stewart recently connected with researchers Prof. José António P. Da Silva and Dr. Ricardo J.O. Ferreira from the University of Coimbra ...  > MORE
There are more than 7,000 rare diseases and of those 90% are without an FDA-approved treatment. Sharing rare disease data is difficult for a number of ...  > MORE
In 2018, Vivli launched its first data analysis challenges to encourage researchers to search and request studies available on the Vivli platform. Since then, we ...  > MORE
  Vivli has waived fees associated with data contributions from academic researchers located in low-and-middle-income countries. “We decided to waive these fees as it was important ...  > MORE
Center for Biomedical Research Transparency (CBMRT) is hosting its fourth annual global summit series with the intention to engage a diverse group of participants with ...  > MORE
Vivli is delighted to launch the first in a series of training videos aimed at researchers interested in accessing individual participant level data (IPD). These ...  > MORE
Vivli Executive Director, Rebecca Li, will join Critical Path Institute’s Jane Larkindale and Debra Miller from CureDuchenne for a session on Data Sharing of Rare ...  > MORE
Vivli Co-Founder Dr. Ida Sim will lead a dkNET webinar entitled “Vivli: A Global Clinical Trials Data Sharing Platform”. dkNET is a search portal that ...  > MORE
“Vivli Global Researchers and Key Stakeholders – Creating Impact” On November 10th, we gathered for a lively discussion as part of our 2020 Annual Meeting. ...  > MORE
“We are delighted that AstraZeneca is joining as a Vivli member and making it possible for researchers to access the data from their clinical trials,” ...  > MORE
Vivli is excited to announce it’s newest publication entitled Timely access to trial data in the context of a pandemic: the time is now. The article, ...  > MORE
Vivli Executive Director, Rebecca Li, will take part in a panel discussion next week as part of Northeastern University’s Center for Law, Innovation and Creativity ...  > MORE
Vivli’s Director of Strategy and Operations, Julie Wood, will be presenting at the 2020 European Medical Writers Association 2020 Virtual Symposium on 6 November 2020. ...  > MORE
September 3 at 11AM ET This 60-minute webinar will explore the emergence of synthetic data, a privacy preservation approach to protect individual patient data. Top ...  > MORE
Vivli Executive Director, Rebecca Li, will take part in a panel discussion as part of Data Sharing to Accelerate Therapeutic Development for Rare Diseases hosted ...  > MORE
Vivli extends a warm welcome to our newest member, Mitsubishi Tanabe Pharma. “We are delighted to include Mitsubishi Tanabe studies on the Vivli platform,” said ...  > MORE
“We are delighted to welcome Taiho Pharma as a member of Vivli and to be able to partner with them to manage requests received for ...  > MORE
Members of Vivli, the Center for Clinical Research Data, announce today their commitment to share their COVID-19 trials through Vivli. Members who have committed to ...  > MORE
RECORDING Join Vivli, COVID Collaboration Platform (CP) and TransCelerate BioPharma for a discussion of how these organizations are working to support academia, foundations and industry ...  > MORE
“We are thrilled to welcome Roche as a member of Vivli and to be able to list their studies on the platform,” said Rebecca Li, ...  > MORE
Regeneron joins Vivli, reinforcing their commitment to data transparency “We are pleased to welcome Regeneron as a member of Vivli,” said Rebecca Li, Vivli Executive ...  > MORE
Access to data from completed coronavirus trials would be made available to all qualified researchers Cambridge, MA–In a visible sign of data sharing leadership, Vivli, ...  > MORE
Dr. John Frew, the first Pioneer Award winner, from Rockefeller University, sat down for an interview with Vivli to share more about his research, the ...  > MORE
Vivli launched its first data analysis challenge shortly after our launch in an effort to generate interest and move data sharing forward. We are delighted ...  > MORE
VIEW HERE Join Vivli for a webinar discussing the differences between Real-World Data (RWD) and Real-World Evidence (RWE), and clinical trials. Different types of study ...  > MORE
We are delighted to share with you Vivli’s 2019 Progress Report, which highlights our milestones to date and plans for the year ahead. We look forward ...  > MORE
Few things are more frustrating than wasted time. The Vivli team wants to help you make the most of your valuable time, and to help ...  > MORE
“We are delighted to have Johnson & Johnson join Vivli as a member,” said Rebecca Li, Vivli Executive Director. “This partnership will drive science forward ...  > MORE
Long-term cancer survivor and patient advocate Jane Perlmutter tells us why data sharing is so important for people with rare diseases. Q: Why should we ...  > MORE
By Rebecca Li, Vivli Executive Director I started my career at a small biotech company and understand the intensity of the start-up experience as well ...  > MORE
 In June of 2017, the International Committee of Medical Journal Editors, or ICMJE, released new requirements for data sharing statements, for submissions to their publications. The ...  > MORE
January 7, 2019 | What is IPD meta-analysis?
Meta-analysis is a statistical technique for combining sources of quantitative evidence. It is an example of secondary analysis, which is a subsequent analysis of clinical ...  > MORE
Ida Sim, Technical Lead, Vivli As increasing numbers of funders introduce requirements for data sharing plans, researchers have to develop a new skill: how to ...  > MORE
Vivli is an innovative new clinical research data sharing platform with a robust search engine that has been created to meet the needs of researchers ...  > MORE